Lantheus submits drug master file for imaging biomarker
Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it...Read more on AuntMinnie.comRelated Reading:
Point Biopharma to use Lantheus' PyL in clinical trial
Lantheus divests Puerto Rico nuclear medicine businesses
FDA clears Lantheus' AI bone software
Sofie, Lantheus ink deal for prostate cancer imaging agent
Lantheus reports mixed Q3 results
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Nuclear Medicine | Prostate Cancer | Radiology